Piramal Pharma Limited finalise l'acquisition d'une participation majoritaire dans Yapan Bio Private Limited

Positive

AI Analysis

Summary

Piramal Pharma Limited has finalized the acquisition of a majority stake in Yapan Bio Private Limited, a company specializing in process development, characterization, and GMP-compliant manufacturing services for Phase I and II vaccines and biologics.

Importance:6/10

Sentiment:

0.50

acquisitionmajority stakevaccine manufacturingbiologicsGMP services

Read the original article

Published by PR Newswire Pharma on August 19, 2026 3:21 PM

Read Original